Clinical trial
The Effect of Sildenafil in Preterm Infants With Evolving Chronic Lung Disease
NCT00431418 · Mercy Hospital for Women, Australia, Other · Completed
Key facts
| NCT number | NCT00431418 |
|---|---|
| Title | The Effect of Sildenafil in Preterm Infants With Evolving Chronic Lung Disease |
| Official title | The Effect of Sildenafil in Preterm Infants With Evolving Chronic Lung Disease (SPICE Trial): a Pilot Study |
| Lead sponsor | Mercy Hospital for Women, Australia, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Diseases |
| Intervention type | Drug |
| Interventions | Sildenafil, Placebo |
| Enrollment | 20 |
| Start date | Jan 1, 2007 |
| Primary completion | Jul 1, 2010 |
| Completion | Jun 1, 2012 |
| First posted | Feb 5, 2007 |
| Last update posted | Sep 23, 2015 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: